Gt Biopharma, Inc. (NASDAQ:GTBP)

Tuesday, August 3, 2021 | Web News
Gt Biopharma (NASDAQ:GTBP) ($11.26, $237.8m market cap) a clinical stage immunology company announced preclinical results for GTB-5550,...
Wednesday, May 12, 2021 | Web News
Gt Biopharma (NASDAQ:GTBP) ($15.1, $428.7m market cap) a clinical stage immunology company announced an update on the commencement of the...
See All Research...
GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer.

Web site: http://www.gtbiopharma.com

Last updated March 26, 2021


Market Data powered by QuoteMedia. Terms of Use